Annual Current Assets
$149.87 M
+$53.45 M+55.44%
31 December 2023
Summary:
Taysha Gene Therapies annual total current assets is currently $149.87 million, with the most recent change of +$53.45 million (+55.44%) on 31 December 2023. During the last 3 years, it has fallen by -$108.01 million (-41.88%). TSHA annual current assets is now -41.88% below its all-time high of $257.88 million, reached on 31 December 2020.TSHA Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$161.56 M
-$16.91 M-9.48%
30 September 2024
Summary:
Taysha Gene Therapies quarterly total current assets is currently $161.56 million, with the most recent change of -$16.91 million (-9.48%) on 30 September 2024. Over the past year, it has dropped by -$10.25 million (-5.97%). TSHA quarterly current assets is now -42.14% below its all-time high of $279.24 million, reached on 30 September 2020.TSHA Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +55.4% | -6.0% |
| 3 y3 years | -41.9% | -18.1% |
| 5 y5 years | - | - |
TSHA Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -41.9% | +55.4% | -18.1% | +275.7% |
| 5 y | 5 years | -41.9% | >+9999.0% | -42.1% | +1329.8% |
| alltime | all time | -41.9% | >+9999.0% | -42.1% | +1329.8% |
Taysha Gene Therapies Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $161.56 M(-9.5%) |
| June 2024 | - | $178.47 M(+36.7%) |
| Mar 2024 | - | $130.60 M(-12.9%) |
| Dec 2023 | $22.86 M(-23.4%) | $149.87 M(-12.8%) |
| Sept 2023 | - | $171.81 M(+217.5%) |
| June 2023 | - | $54.12 M(-25.2%) |
| Mar 2023 | - | $72.36 M(-25.0%) |
| Dec 2022 | $29.86 M | $96.42 M(+124.2%) |
| Sept 2022 | - | $43.00 M(-44.0%) |
| June 2022 | - | $76.83 M(-28.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $106.89 M(-33.0%) |
| Dec 2021 | $54.35 M(+5324.6%) | $159.60 M(-19.1%) |
| Sept 2021 | - | $197.17 M(-4.9%) |
| June 2021 | - | $207.30 M(-13.5%) |
| Mar 2021 | - | $239.63 M(-7.1%) |
| Dec 2020 | $1.00 M(>+9900.0%) | - |
| Dec 2020 | - | $257.88 M(-7.6%) |
| Sept 2020 | - | $279.24 M(+2371.4%) |
| June 2020 | - | $11.30 M |
| Dec 2019 | $0.00 | - |
FAQ
- What is Taysha Gene Therapies annual total current assets?
- What is the all time high annual current assets for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual current assets year-on-year change?
- What is Taysha Gene Therapies quarterly total current assets?
- What is the all time high quarterly current assets for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly current assets year-on-year change?
What is Taysha Gene Therapies annual total current assets?
The current annual current assets of TSHA is $149.87 M
What is the all time high annual current assets for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual total current assets is $257.88 M
What is Taysha Gene Therapies annual current assets year-on-year change?
Over the past year, TSHA annual total current assets has changed by +$53.45 M (+55.44%)
What is Taysha Gene Therapies quarterly total current assets?
The current quarterly current assets of TSHA is $161.56 M
What is the all time high quarterly current assets for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly total current assets is $279.24 M
What is Taysha Gene Therapies quarterly current assets year-on-year change?
Over the past year, TSHA quarterly total current assets has changed by -$10.25 M (-5.97%)